They discovered that the level of SOX9 was downregulated by the proposed target miRNA, miR-101, which was also confirmed by the luciferase reporter assay, suggesting that miRNA-101 directly targets SOX9 in HCC tissues. Here, SOX9 is linked to hepatocellular carcinoma.